Using pharmacogenetics in real time to guide therapy: the warfarin example


  • F. Aminkeng

    Corresponding author
    1. The Canadian Pharmacogenomic Network for Drug Safety (CPNDS), Center for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
    Search for more papers by this author

No abstract is available for this article.